Maravai Lifesciences Stock Options
| MRVI Stock | USD 2.26 0.14 5.83% |
Maravai Lifesciences' latest option contracts expiring on June 20th 2025 are carrying combined implied volatility of 2.2 with a put-to-call open interest ratio of 0.1 over 12 outstanding agreements suggesting investors are buying way more calls than puts on contracts expiring on June 20th 2025. The total put volume is at 1.0, with calls trading at the volume of 210. This yields a 0.0 put-to-call volume ratio.
Open Interest Against June 20th 2025 Option Contracts
2025-06-20
The chart above shows Maravai Lifesciences' distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. Maravai Lifesciences' open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for Maravai Lifesciences' option, there is no secondary market available for investors to trade.
In The Money vs. Out of Money Option Contracts on Maravai Lifesciences
Analyzing Maravai Lifesciences' in-the-money options over time can help investors to take a profitable long position in Maravai Lifesciences regardless of its overall volatility. This is especially true when Maravai Lifesciences' options are deep in the money. These options can be identified using deltas that are over 0.75. Deep in-the-money Maravai Lifesciences' options could be used as guardians of the underlying stock as they move almost dollar for dollar with Maravai Lifesciences' stock while costing only a fraction of its price.
Maravai Current Options Market Mood
Maravai Lifesciences' open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Maravai Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.
Put-to-Call Open Interest
Put-to-Call Volume
Unfortunately, most Maravai Lifesciences' options investors are not very successful. Maravai Lifesciences' option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction.
Rule 16 of the current Maravai contract
Base on the Rule 16, the options market is currently suggesting that Maravai Lifesciences Holdings will have an average daily up or down price movement of about 0.14% per day over the life of the 2025-06-20 option contract. With Maravai Lifesciences trading at USD 2.26, that is roughly USD 0.003107. If you think that the market is fully incorporating Maravai Lifesciences' daily price movement you should consider buying Maravai Lifesciences Holdings options at the current volatility level of 2.2%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Maravai |
Purchasing Maravai Lifesciences options can give investors a meaningful hedge against losses and, therefore, could be used conservatively to decrease the volatility of your portfolio. However, many options could also amount to little more than gambling, significantly enhancing your overall portfolio risk. One simple example of these aggressive strategies is the sale of "uncovered" Maravai calls. Remember, the seller must deliver Maravai Lifesciences Holdings stock to the call owner when a call is exercised.
Maravai Lifesciences Option Chain
When Maravai Lifesciences' strike price is surpassing the current stock price, the option contract against Maravai Lifesciences Holdings stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
Maravai Lifesciences' option chain is a display of a range of information that helps investors for ways to trade options on Maravai. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Maravai. It also shows strike prices and maturity days for a Maravai Lifesciences against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone. | Open Int | Strike Price | Current Spread | Last Price | |||
Call | MRVI250620C00015000 | 0 | 15.0 | 0.0 - 0.55 | 0.55 | |
Call | MRVI250620C00012500 | 1 | 12.5 | 0.0 - 1.6 | 0.1 | Out |
Call | MRVI250620C00010000 | 261 | 10.0 | 0.0 - 0.1 | 0.05 | Out |
Call | MRVI250620C00007500 | 287 | 7.5 | 0.0 - 0.5 | 0.05 | Out |
Call | MRVI250620C00005000 | 171 | 5.0 | 0.1 - 0.3 | 0.15 | Out |
Call | MRVI250620C00002500 | 312 | 2.5 | 0.35 - 0.95 | 0.45 | Out |
Put | MRVI250620P00015000 | 0 | 15.0 | 11.2 - 13.6 | 11.2 | In |
Put | MRVI250620P00012500 | 0 | 12.5 | 9.7 - 11.0 | 9.7 | In |
Put | MRVI250620P00010000 | 0 | 10.0 | 7.2 - 8.6 | 7.2 | In |
Put | MRVI250620P00007500 | 0 | 7.5 | 4.6 - 6.1 | 2.5 | In |
Put | MRVI250620P00005000 | 92 | 5.0 | 2.45 - 2.95 | 2.6 | In |
Put | MRVI250620P00002500 | 10 | 2.5 | 0.2 - 1.0 | 0.6 | In |
Maravai Total Stockholder Equity
Total Stockholder Equity |
|
Maravai Lifesciences Corporate Management
| Kurt Oreshack | General VP | Profile | |
| Christine Dolan | Executive Technologies | Profile | |
| Brian Neel | Chief Production | Profile | |
| Peter Leddy | Executive Officer | Profile | |
| Christopher Benoit | Executive Enzymes | Profile | |
| Becky Buzzeo | Executive Officer | Profile |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Maravai Lifesciences Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Maravai Lifesciences. If investors know Maravai will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Maravai Lifesciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.33) | Earnings Share (1.05) | Revenue Per Share | Quarterly Revenue Growth (0.24) | Return On Assets |
The market value of Maravai Lifesciences is measured differently than its book value, which is the value of Maravai that is recorded on the company's balance sheet. Investors also form their own opinion of Maravai Lifesciences' value that differs from its market value or its book value, called intrinsic value, which is Maravai Lifesciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Maravai Lifesciences' market value can be influenced by many factors that don't directly affect Maravai Lifesciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Maravai Lifesciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Maravai Lifesciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Maravai Lifesciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.